arrow
T

Tamsin Morris

astrazeneca
H指数:13
被引数:539

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness of Budesonide/Glycopyrronium/Formoterol (BGF) Fixed-Dose Combination in Patients with COPD (RECORD Study): A Prospective Observational Study

布地奈德/格隆溴铵/福莫特罗(BGF)固定剂量组合在COPD患者中的真实世界有效性(RECORD研究):一项前瞻性观察性研究

2026-10-300
OAAI
Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom

英国关于在射血分数降低的心力衰竭患者中启动达格列净的观察性研究

2026-09-080
OA
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab

克服重度嗜酸性粒细胞哮喘缓解障碍: Benralizumab两年真实世界数据

2024-07-311
OAAI
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
2024-04-014
OA
Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study
2023-06-018
OAAI
Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals

用机器学习识别慢性肾脏病的亚型: 在350,067个人中使用链接的电子健康记录进行开发,内部验证和预后验证

2023-03-013
OAAI
Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19-a data-driven retrospective cohort study

使用国家电子健康记录进行大流行准备: 验证COVID-19-a数据驱动的回顾性队列研究中预测超额死亡的简约模型

2022-11-142
OA
A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease

一项预测和验证新型冠状病毒肺炎大流行对慢性肾脏病患者影响的回顾性队列研究

2022-09-0118
OAAI